Interventional Study Exploring the Occurrence of Surgical Site Infections.

NCT06661473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2026-03-31

No results posted yet for this study

Summary

Interventional study exploring surgical site complication occurrences in high-risk revision patients undergoing TKA or THA using NPWT.

Conditions

  • Total Knee Arthroplasty
  • Total Hip Arthroplasty Revision
  • Total Knee Arthroplasty Revision

Interventions

DEVICE

Avance Solo Negative Pressure Wound Therapy

Avance Solo NPWT 7-14 days after high-risk revision TKA or THA.

Sponsors & Collaborators

  • Molnlycke Health Care AB

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-03
Primary Completion
2025-12-23
Completion
2025-12-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06661473 on ClinicalTrials.gov